日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Protect or prevent? A practicable framework for the dilemmas of COVID-19 vaccine prioritization

保护还是预防?新冠肺炎疫苗优先接种两难困境的实用框架

Arghal, Raghu; Rubin, Harvey; Saeedi Bidokhti, Shirin; Sarkar, Saswati

Editorial: Pandemic-driven telehealth uptake: the missing healthcare provider, system and patient voices

社论:疫情推动远程医疗普及:医疗服务提供者、系统和患者的声音被忽视了

Michel, Janet; Kawonga, Mary; Rubin, Harvey

Fault Detection for Vaccine Refrigeration via Convolutional Neural Networks Trained on Simulated Datasets

基于模拟数据集训练的卷积神经网络在疫苗冷藏故障检测中的应用

Abhiraman, Bhaskar; Fotis, Riley; Eskin, Leo; Rubin, Harvey

Small Molecules Targeting Mycobacterium tuberculosis Type II NADH Dehydrogenase Exhibit Antimycobacterial Activity

靶向结核分枝杆菌II型NADH脱氢酶的小分子表现出抗分枝杆菌活性

Harbut, Michael B; Yang, Baiyuan; Liu, Renhe; Yano, Takahiro; Vilchèze, Catherine; Cheng, Bo; Lockner, Jonathan; Guo, Hui; Yu, Chenguang; Franzblau, Scott G; Petrassi, H Mike; Jacobs, William R Jr; Rubin, Harvey; Chatterjee, Arnab K; Wang, Feng

Stringent Response Factors PPX1 and PPK2 Play an Important Role in Mycobacterium tuberculosis Metabolism, Biofilm Formation, and Sensitivity to Isoniazid In Vivo

严格应答因子PPX1和PPK2在结核分枝杆菌的代谢、生物膜形成以及体内对异烟肼的敏感性中发挥重要作用

Chuang, Yu-Min; Dutta, Noton K; Hung, Chien-Fu; Wu, T-C; Rubin, Harvey; Karakousis, Petros C

A high-throughput small-molecule screen to identify a novel chemical inhibitor of Clostridium difficile.

利用高通量小分子筛选方法鉴定一种新型艰难梭菌化学抑制剂

Katzianer David S, Yano Takahiro, Rubin Harvey, Zhu Jun

Rapid analysis of pharmacology for infectious diseases

传染病药理学的快速分析

Hopkins, Andrew L; Bickerton, G Richard; Carruthers, Ian M; Boyer, Stephen K; Rubin, Harvey; Overington, John P

Systematic analysis of conservation relations in Escherichia coli genome-scale metabolic network reveals novel growth media

对大肠杆菌基因组规模代谢网络中保守关系的系统分析揭示了新型生长培养基

Imielinski, Marcin; Belta, Calin; Rubin, Harvey; Halász, Adam

Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs

II型NADH:甲萘醌氧化还原酶抑制剂是一类抗结核药物。

Weinstein, Edward A; Yano, Takahiro; Li, Lin-Sheng; Avarbock, David; Avarbock, Andrew; Helm, Douglas; McColm, Andrew A; Duncan, Ken; Lonsdale, John T; Rubin, Harvey